These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37766336)

  • 1. An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein.
    Ho C; Nazarie WFWM; Lee PC
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
    Matveev EV; Ponomarev GV; Kazanov MD
    Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    Begum F; Srivastava AK; Tripathi PP; Ray U
    J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
    Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR
    ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic activation of SARS-CoV-2 spike protein.
    Takeda M
    Microbiol Immunol; 2022 Jan; 66(1):15-23. PubMed ID: 34561887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
    Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
    Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases.
    Shokeen K; Pandey S; Shah M; Kumar S
    Virus Res; 2022 Sep; 318():198845. PubMed ID: 35680004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of host proteases in the entry of SARS-CoV-2.
    Zabiegala A; Kim Y; Chang KO
    Anim Dis; 2023; 3(1):12. PubMed ID: 37128508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of Proteolytic Cleavage Sites towards the N-Terminal End of the S2 Subunit of the Novel SARS-CoV-2 Omicron Sublineage BA.2.12.1.
    Schilling NA; Kalbacher H; Burster T
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
    Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
    mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
    Belouzard S; Chu VC; Whittaker GR
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5871-6. PubMed ID: 19321428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
    Hoffmann M; Kleine-Weber H; Pöhlmann S
    Mol Cell; 2020 May; 78(4):779-784.e5. PubMed ID: 32362314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion.
    Jaiswal D; Kumar U; Gaur V; Salunke DM
    Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2.
    Thaingtamtanha T; Baeurle SA
    J Mol Model; 2022 Jul; 28(8):224. PubMed ID: 35854129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.
    Barrett CT; Neal HE; Edmonds K; Moncman CL; Thompson R; Branttie JM; Boggs KB; Wu CY; Leung DW; Dutch RE
    J Biol Chem; 2021 Jul; 297(1):100902. PubMed ID: 34157282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
    Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP
    J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.
    Bollavaram K; Leeman TH; Lee MW; Kulkarni A; Upshaw SG; Yang J; Song H; Platt MO
    Protein Sci; 2021 Jun; 30(6):1131-1143. PubMed ID: 33786919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.